Wei Tan

7.5k total citations · 6 hit papers
83 papers, 5.7k citations indexed

About

Wei Tan is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine and Immunology. According to data from OpenAlex, Wei Tan has authored 83 papers receiving a total of 5.7k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Molecular Biology, 19 papers in Cardiology and Cardiovascular Medicine and 18 papers in Immunology. Recurrent topics in Wei Tan's work include CRISPR and Genetic Engineering (11 papers), Congenital heart defects research (10 papers) and Cardiac Fibrosis and Remodeling (9 papers). Wei Tan is often cited by papers focused on CRISPR and Genetic Engineering (11 papers), Congenital heart defects research (10 papers) and Cardiac Fibrosis and Remodeling (9 papers). Wei Tan collaborates with scholars based in United States, China and Germany. Wei Tan's co-authors include Eric N. Olson, Rhonda Bassel‐Duby, Joseph A. Hill, Xiaoxia Qi, Ahmed I. Mahmoud, Enzo R. Porrello, Hesham A. Sadek, John McAnally, Callum Kay and Yansong Xue and has published in prestigious journals such as Nature, Science and Cell.

In The Last Decade

Wei Tan

79 papers receiving 5.6k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Heart repair by reprogramming non-myocytes with cardiac transcription factors

2012 860 citations Wei Tan, Rhonda Bassel‐Duby et al. profile →
Hippo pathway effector Yap promotes cardiac regeneration

2013 689 citations John McAnally, Wei Tan et al. profile →
Macrophages are required for neonatal heart regeneration

2014 610 citations Wei Tan, Rhonda Bassel‐Duby et al. Journal of Clinical Investigation profile →
Emerging Activators and Regulators of Inflammasomes and Pyroptosis

2019 408 citations Wei Tan et al. profile →
Doxorubicin Blocks Cardiomyocyte Autophagic Flux by Inhibiting Lysosome Acidification

2016 359 citations Wei Tan et al. Circulation profile →
Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice

2023 102 citations Andreas C. Chai, Miao Cui et al. Nature Medicine profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wei Tan United States	31	3.8k	1.3k	1.2k	808	560	83	5.7k
Thomas G. Gillette United States	39	3.3k 0.9×	1.6k 1.2×	581 0.5×	821 1.0×	433 0.8×	67	5.6k
Tianqing Peng Canada	43	3.5k 0.9×	1.5k 1.1×	519 0.4×	843 1.0×	866 1.5×	113	6.0k
Yasuhiro Maejima Japan	35	3.0k 0.8×	1.3k 1.0×	697 0.6×	748 0.9×	573 1.0×	121	6.2k
Weidong Zhu China	30	2.3k 0.6×	1.3k 1.0×	520 0.4×	279 0.3×	343 0.6×	102	4.3k
Jun Yu United States	44	3.9k 1.0×	774 0.6×	710 0.6×	1.4k 1.7×	1.0k 1.8×	111	6.6k
Tetsuaki Hirase Japan	27	3.0k 0.8×	512 0.4×	597 0.5×	584 0.7×	620 1.1×	57	6.1k
Hideyuki Yamawaki Japan	43	2.2k 0.6×	1.4k 1.1×	681 0.6×	348 0.4×	603 1.1×	169	5.8k
Y. Eugene Chen United States	39	2.6k 0.7×	567 0.4×	861 0.7×	419 0.5×	699 1.2×	143	5.0k
Benjamin J. Wilkins United States	31	3.0k 0.8×	1.4k 1.0×	753 0.6×	344 0.4×	326 0.6×	66	4.2k
Jane‐Lise Samuel France	58	3.8k 1.0×	3.7k 2.8×	1.5k 1.3×	722 0.9×	506 0.9×	184	8.0k

Countries citing papers authored by Wei Tan

Since Specialization

Citations

This map shows the geographic impact of Wei Tan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei Tan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei Tan more than expected).

Fields of papers citing papers by Wei Tan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei Tan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei Tan. The network helps show where Wei Tan may publish in the future.

Co-authorship network of co-authors of Wei Tan

This figure shows the co-authorship network connecting the top 25 collaborators of Wei Tan. A scholar is included among the top collaborators of Wei Tan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei Tan. Wei Tan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Tadokoro, Tomonori, et al.. (2026). Ablation of PKCα Phosphorylation by CRISPR-Cas9 Base Editing Rescues Heart Failure. Circulation Research. 138(7). e326738–e326738.

Tan, Wei, Xiaona Zhang, Hongxian Xie, et al.. (2025). Synergistic effect of rhenium and tungsten in nickel-based model single crystal superalloys. Journal of Materials Research and Technology. 35. 6965–6975. 2 indexed citations

Amas, Junrey C., Philipp E. Bayer, Wei Tan, et al.. (2025). Genome‐wide identification and evolutionary analysis of disease resistance genes in Brassica carinata. The Plant Genome. 18(3). e70087–e70087. 1 indexed citations

Zhang, Yi, Chanjuan Chen, Wei Tan, et al.. (2025). Pkd2l1 deletion inhibits the neurogenesis of cerebrospinal fluid-contacting neurons and impedes spinal cord injury repair. Cell Death Discovery. 11(1). 194–194.

Garry, Glynnis A., Matthieu Dos Santos, Wei Tan, et al.. (2025). Cellular Reprogramming by PHF7 Enhances Cardiac Function Following Myocardial Infarction. Circulation. 152(9). 616–629. 2 indexed citations

Wang, Shiwei, Hanqing Wang, Xiaoou Yi, et al.. (2024). Damage recovery stages revisited: Thermal evolution of non-saturated and saturated displacement damage in heavy-ion irradiated tungsten. Acta Materialia. 273. 119942–119942. 7 indexed citations

Chai, Andreas C., Miao Cui, Francesco Chemello, et al.. (2023). Base editing correction of hypertrophic cardiomyopathy in human cardiomyocytes and humanized mice. Nature Medicine. 29(2). 401–411. 102 indexed citations breakdown →

Lebek, Simon, Xurde M. Caravia, Leon G. Straub, et al.. (2023). CRISPR-Cas9 base editing of pathogenic CaMKIIδ improves cardiac function in a humanized mouse model. Journal of Clinical Investigation. 134(1). 20 indexed citations

Lebek, Simon, Xurde M. Caravia, Francesco Chemello, et al.. (2023). Elimination of CaMKIIδ Autophosphorylation by CRISPR-Cas9 Base Editing Improves Survival and Cardiac Function in Heart Failure in Mice. Circulation. 148(19). 1490–1504. 13 indexed citations

10.

Garry, Glynnis A., Matthieu Dos Santos, Wei Tan, et al.. (2023). Abstract 18042: Induction of Cardiac Reprogramming Following Injury Through Delivery of a Single Factor, PHF7. Circulation. 148(Suppl_1). 1 indexed citations

11.

Cao, Liang, Wei Tan, Gang Liu, et al.. (2023). Culture of cerebrospinal fluid-contacting neurons from neonatal mouse spinal cord. Cell and Tissue Banking. 25(2). 443–452. 2 indexed citations

12.

Tan, Wei, Cong Wang, Qing Yuan, et al.. (2023). Room-temperature ferromagnetism in Fe-doped SnSe bulk single crystalline semiconductor. Materials Today Physics. 38. 101251–101251. 5 indexed citations

13.

Lebek, Simon, Francesco Chemello, Xurde M. Caravia, et al.. (2023). Ablation of CaMKIIδ oxidation by CRISPR-Cas9 base editing as a therapy for cardiac disease. Science. 379(6628). 179–185. 73 indexed citations

14.

Gan, Peiheng, Zhaoning Wang, Svetlana Bezprozvannaya, et al.. (2023). RBPMS regulates cardiomyocyte contraction and cardiac function through RNA alternative splicing. Cardiovascular Research. 120(1). 56–68. 18 indexed citations

15.

Voillet, Valentin, Trisha R. Berger, Kelly M. McKenna, et al.. (2022). An In Vivo Model of Human Macrophages in Metastatic Melanoma. The Journal of Immunology. 209(3). 606–620. 7 indexed citations

16.

Nishiyama, Takahiko, Yu Zhang, Miao Cui, et al.. (2022). Precise genomic editing of pathogenic mutations in RBM20 rescues dilated cardiomyopathy. Science Translational Medicine. 14(672). eade1633–eade1633. 103 indexed citations

17.

Cui, Miao, Ayhan Atmanli, María Gabriela Morales, et al.. (2021). Nrf1 promotes heart regeneration and repair by regulating proteostasis and redox balance. Nature Communications. 12(1). 5270–5270. 83 indexed citations

18.

Tan, Wei, Pei Jiang, Wanjun Zhang, et al.. (2021). Posttranscriptional regulation of de novo lipogenesis by glucose-induced O-GlcNAcylation. Molecular Cell. 81(9). 1890–1904.e7. 66 indexed citations

19.

Tan, Wei, et al.. (2020). [Pyridoxal kinase (PDXK) promotes the proliferation of serous ovarian cancer cells and is associated with poor prognosis].. PubMed. 36(6). 542–548. 2 indexed citations

20.

Xie, Ting, et al.. (2018). microRNA‐183 improve myocardial damager via NF‐kb pathway: In vitro and in vivo study. Journal of Cellular Biochemistry. 120(6). 10145–10154. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact